Echocardiography in Cardiac Resynchronization Therapy (Echo-CRT)
Launched by LILLE CATHOLIC UNIVERSITY · Dec 6, 2016
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Echo-CRT clinical trial is studying how certain heart imaging techniques, specifically echocardiography, can help predict how well patients with heart failure will respond to a treatment called Cardiac Resynchronization Therapy (CRT). This therapy is designed to help the heart pump more effectively when it is not working properly. The researchers are looking for specific heart movement patterns that can indicate a better chance of success with this treatment.
To be eligible for the trial, participants should have heart failure with a weak heart muscle (meaning their heart does not pump blood efficiently) and a specific type of electrical pattern in their heart rhythm. Participants must also have a clear need for CRT based on their medical condition. If you join this study, you will undergo heart imaging tests to help understand how these new techniques can improve treatment outcomes for people with heart failure. The trial is open to anyone aged 65 and older, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Heart failure with left ventricular ejection fraction less than 35 %
- • QRS duration over than 120 ms
- • Clinical indication for CRT
- Exclusion Criteria:
- • Rythmologic indication of CRT for atrial fibrillation control
- • Rythmologic indication of CRT for left ventricular ejection fraction between 35% and 45%
About Lille Catholic University
Lille Catholic University, a prominent academic institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates expertise from various fields to foster the development of cutting-edge medical solutions. Its commitment to ethical standards and patient-centered approaches ensures that clinical trials conducted under its auspices are rigorous, scientifically sound, and aligned with the highest standards of care. By leveraging its extensive network of researchers, healthcare professionals, and resources, Lille Catholic University plays a vital role in contributing to the enhancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lomme, , France
Patients applied
Trial Officials
Sylvestre Maréchaux, MD, PhD
Principal Investigator
Hospital of Lille Catholic University (GHICL)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials